CG
ARKG icon

Cutler Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cutler Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$112K Sell
3,899
-10,304
-73% -$310K 0.04% 419
2023
Q4 		$466K Buy
14,203
+13,099
+1,187% +$356K 0.04% 444
2023
Q3 		$30K Sell
1,104
-46
-4% -$1.5K ﹤0.01% 1763
2023
Q2 		$39K Buy
+1,150
New +$36.1K 0.01% 1433
2023
Q1 		– Sell
-11,428
Closed -$354K – 3748
2022
Q4 		$322K Buy
11,428
+90
+0.8% +$2.86K 0.03% 587
2022
Q3 		$372K Buy
11,338
+4,879
+76% +$179K 0.03% 668
2022
Q2 		$203K Sell
6,459
-9,061
-58% -$317K 0.01% 993
2022
Q1 		$712K Buy
15,520
+11,920
+331% +$568K 0.04% 529
2021
Q4 		$220K Buy
3,600
+1,800
+100% +$124K 0.01% 1241
2021
Q3 		$134K Buy
1,800
+407
+29% +$34.1K 0.01% 1672
2021
Q2 		$128K Sell
1,393
-407
-23% -$34.6K 0.01% 1663
2021
Q1 		$159K Sell
1,800
-3,496
-66% -$347K 0.01% 1424
2020
Q4 		$493K Buy
5,296
+492
+10% +$39.2K 0.02% 637
2020
Q3 		$306K Buy
+4,804
New +$282K 0.02% 722

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Cutler Group's ARKG Position: Q1 2024 in Review

Cutler Group reduced its ARK Genomic Revolution ETF (ARKG) stake by 73% in Q1 2024, selling an estimated $310K and leaving 3,899 shares worth $112K. The position accounts for 0.04% of the portfolio, ranked #419.

Cutler Group first reported a position in ARKG in Q3 2020 and has held it in 14 quarters since. The position peaked at $712K in Q1 2022. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • Cutler Group held 3,899 shares of ARK Genomic Revolution ETF worth $112K as of Q1 2024.
  • Cutler Group sold 10,304 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $310K.
  • ARK Genomic Revolution ETF made up 0.04% of Cutler Group's portfolio in Q1 2024, its #419 holding.
  • Cutler Group first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 14 quarters since.
  • Cutler Group's ARK Genomic Revolution ETF position peaked at $712K in Q1 2022.
  • 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.